The currently recommended schedule collectively has an excellent safety profile.

First case–control study to explore the prevalence of and risk factors for gout in patients with HIV.

Findings from a new review of the evidence, published in the Lancet.

Findings from the Defining best Management for Adults with Chronic Rhinosinusitis (MACRO) programme.

There is a substantial negative impact of multidrug-resistant Gram-negative bacteria on empirical antibiotic therapy for cancer patients—in many cases resulting in mortality. Dr Carlota Gudiol believes that considering patients’ individual risks for antibacterial resistance, and the local epidemiology of treatment centres can help guide clinical decision-making.

According to Professor Victor Nizet, the future of antibiotic treatment may not target the microbes per se, but rather the host–pathogen interface.

A non-antibiotic drug–bacteria screen identified novel interactions, suggesting that some human-targeted drugs significantly impact the gut microbiome, potentially causing side effects and antibiotic resistance. This screen is a resource of representative gut bacteria strains and growth media for further in vitro studies.

By activating the bacterial SOS response, chemotherapy treatments promote antibiotic resistance and bacterial translocation.

NICE has issued a new patient decision aid on inhalers for asthma.

Children and the elderly account for the majority of admissions.

Research from the University of Bristol provides the first evidence of a causal link between sex hormones and asthma.

Effects identified at home and at work in this longitudinal study.

Benralizumab is recommended as an add-on maintenance therapy for the treatment of severe uncontrolled eosinophilic asthma.

The World Health Organization has launched a new global influenza strategy.